Abstract:Objective To investigate the antagonism effect of nicotine on β-amyloid (Aβ) cytotoxicity and its relation with the metabolism of β-amyloid precursor protein (APP). Methods PC12 cells were treated with different concentrations of nicotine and/or Aβ25-35 for 24 hours. Adopted MTT method to determine cellular viability. Western Blot tests were carried out to detect soluble APPα (sAPPα) secretion in the PC12 cellular supernate and the expression level of intercellular insulin degrading enzyme (IDE). Results 1) There was no significant toxic action on PC12 cell at 0.10-500 μmol/L nicotine (P > 0.05, for all), but certain toxic action could be seen when the concentration raised to 1 000 μmol/L (P ≤ 0.05). Aβ25-35 produced significant toxic effect on PC12 cell at the concentration of 1-100 μmol/L (P ≤ 0.01, for all), but it was not seen when concentration decreased to 0.10 μmol/L (P > 0.05). 2) Nicotine presented different action on Aβ25-35-induced cytotoxicity at concentration 0.10-1 000 μmol/L, it can partially antagonize Aβ25-35-induced cytotoxic action at 0.10-100 μmol/L (P < 0.01, for all), but could not recover PC12 cellular viability to normal level (P < 0.01, for all), and could not produce antagonism at 500 μmol/L and 1 000 μmol/L (P > 0.05, for all). 3) Aβ25-35 (20 μmol/L) and/or nicotine (100 μmol/L or 1 000 μmol/L) can increase the secretion level of sAPPα in PC12 cell (P < 0.01, for all). The sAPPα secretion level raised to the highest level at 100 μmol/L nicotine. 4) Aβ25-35 (20 μmol/L) can decrease the expression level of IDE (P < 0.01), 100 μmol/L nicotine can obviously antagonize this action (P < 0.01), but not at a concentration of 1 000 μmol/L (P > 0.05). When PC12 cell was treated with 100 μmol/L and 1 000 μmol/L nicotine separately, IDE expression level was significantly higher than that in normal control group (P < 0.01). Conclusion There is no direct relationship between the nicotine antagonism effect on Aβ25-35-induced cellular toxicity and sAPPα secretion level, but may relate to the expression level of IDE.

Nicotine Modulates Expression of Amyloid Precursor Protein and Amyloid Precursor-Like Protein 2 in Mouse Brain and in SH-SY5Y Neuroblastoma Cells.

Nicotinamide Forestalls Pathology and Cognitive Decline in Alzheimer Mice: Evidence for Improved Neuronal Bioenergetics and Autophagy Procession

Nicotine Enhances the Biosynthesis and Secretion of Transthyretin from the Choroid Plexus in Rats: Implications for Beta-Amyloid Formation

Nicotine Decreases Beta-Amyloid Through Regulating Bace1 Transcription In Sh-Ep1-Alpha 4 Beta 2 Nachr-App695 Cells

Dissecting the Signaling Pathway of Nicotine-Mediated Neuroprotection in A Mouse Alzheimer Disease Model

Nicotine Decreases Beta-Amyloid Through Regulating BACE1 Transcription in SH-EP1-α4β2 nAChR-APP695 Cells

Nicotine Ameliorates α-synuclein Pre-formed Fibril-Induced Behavioral Deficits and Pathological Features in Mice

Low Dose Nicotine Attenuates Aβ Neurotoxicity Through Activation Early Growth Response Gene 1 Pathway

The molecular mechanism of preventive effect of nicotine on Parkinson's disease and Alzheimer's disease

Nicotine Modulates Expression of Dynamin 1 in Rat Brain and SH-SY5Y Cells.

Antagonism effect of nicotine on Aβ25-35 cytotoxicity and its relation with the metabolism of β-amyloid precursor protein

Effects of Nicotine Analog ZY-1 on β-amyloid Production and Learning and Memory in Transgenic Alzheimer Disease Mice

The Therapeutic Effects of Nicotine in Aβ25-35-induced Alzheimer's Disease Models

Cannabinoid Receptor CB1 Is Involved in Nicotine-Induced Protection Against Aβ 1–42 Neurotoxicity in HT22 Cells

Strain- And Region-Specific Gene Expression Profiles In Mouse Brain In Response To Chronic Nicotine Treatment

Nicotine prevents in vivo Aβ toxicity in Caenorhabditis elegans via SKN-1

Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease

Protective Effect of Nicotine on the Cultured Rat Basal Forebrain Neurons Damaged by Β-Amyloid (Aβ)25-35 Protein Cytotoxicity.

Metabolic Divergence Between Healthy and Conditional Presenilin-1/2 knockout Dementia Model Mice under Chronic Nicotine exposure

Regulation by Nicotine of Gpr51 and Ntrk2 Expression in Various Rat Brain Regions.

Neuroprotective Effects of Bioactive Molecules Derived from Tobacco as Potential Therapeutic Candidates for Alzheimer Disease